Megan McArdle's Word Games

Atlantic blogger Megan McArdle wrote a post on pharmaceutical companies last month, and while replying to one of her commenters, she said this:

The United States currently provides something like 80-90% of the profits on new drugs and medical devices. Perhaps you think you can slash profits 80% with no effect on the behavior of the companies that make these products. I don't.

Last week, during a Washington Post online chat, this exchange took place:

Anonymous: You said that medical innovation will be wiped out if we have a type of national health care, because European drug companies get 80% of their revenue from Americans. Where did you get this statistic?

Megan McArdle: It wasn't a statistic--it was a hypothetical.

The mind reels...

COMMENTS (3)

09/02/2009 - 1:21pm EDT |

The mind also reels from her first hypothesizing that 80% of drug profits come from American companies and then positing that the disappearance of all of those profits would harm health care for Europeans. What does she thinks would happen to those American companies from health care reform in this country? That they would be swallowed whole into the earth? A more intelligent commentator would have at least postulated that health care reform would reduce drug company profits by some factor, not wipe them out wholesale, but that intelligent commentator is not Megan McArdle.

09/02/2009 - 2:06pm EDT |

However hypothetical [and ludicrous] McArdle's point is it still does not resolve the question of how important profit is in motivating people to be innovative. And this is why the contest between "selfish" and "selfless" behavior has never really been won or lost. It just gets kicked down the road until someone interpolates it into a new context.

Human motivation is always extremely complex and is ever rooted ambiguously in the manner in which we come to internalize one frame of mind rather than another.

Consider this for example:

Jules Henry quoted in Michael Novak's, The Experience of Nothingness:

"Boris had trouble reducing 12/16 to the lowest terms, and could only get as far as 6/8. The ... view full comment

09/02/2009 - 2:11pm EDT |

I would have a lot more sympathy for the moaning from the likes of Megan McArdle about the research risk faced by pharmaceutical firms had Pfizer, for example, not spent less on R&D ($7.9B) than it spent on dividends ($8.5B) in 2008.

get the magazine

Intellectual rigor. Honest reporting. Influential analysis. Don't miss another issue of the magazine considered "required reading" by the world's top decision-makers. Subscribe today.

Get our newsletters

Get Our Feed